Q&A Highlights: March 2025

About this video

This monthly member Q&A highlights reel focuses heavily on brain and mitochondrial health. Yurth describes autoimmunity as partly a mitochondrial disease, arguing that damaged mitochondria release DNA that triggers inflammation and shifts immune cells toward glucose-driven, pro-inflammatory metabolism. She discusses early bone loss when estrogen falls and why she considers timely hormone replacement plus bone-supporting factors important, while noting claims that GLP-1 medicines may support bone-building cells. She compares plasmalogens and an NAD-related compound as complementary rather than interchangeable, reviews neuroprotective options including nasal approaches, and cautions that methylene blue’s mitochondrial benefits come with nitric-oxide inhibition she considers underappreciated. A final segment links calcific tendonitis to metabolic and hormonal optimization.

Key takeaways

• Ask how mitochondrial damage could be driving inflammation before only suppressing symptoms
• Do not wait for advanced bone loss before addressing estrogen decline
• Compare interventions by mechanism and patient labs, not by popularity
• Check downstream effects — such as nitric-oxide inhibition — before long-term use of a mitochondrial aid
• Treat unusual tendon calcification as a prompt to review metabolic and thyroid health

Episode details: published March 27, 2025 · 106 views · 10:57 long. Summary written by Self Growth Videos from the episode itself. The longevity and peptide concepts described are Dr. Elizabeth Yurth’s, presented for education — not medical advice. Consult a qualified professional before changing your own health practices. Disclosure: Dr. Yurth is co-founder and Chief Medical Officer of the Boulder Longevity Institute, a clinic, and BLI Academy sells clinician education.

← Previous: Can Ozempic Clear Brain Fog? · Next: What Are Peptides? →

All Dr. Elizabeth Yurth videos · Dr. Elizabeth Yurth profile · Boulder Longevity Institute (official site)